Mad Money

Cramer: Theranos news sparked the rally for this stock

It's that time again! Jim Cramer rang the lightning round bell, which means he gave his take on caller favorite stocks at rapid speed:

Old Republic International: "That is a stay-the-course insurance company. It's an old, good company. Travelers reports next week, that one is good, too. That one is fine and I like the dividend."

Quest Diagnostics Inc: "Do you know this stock got hit when Theranos was starting to roar, and then since Theranos kind of imploded it has been going up? I think it has gone up too much. At this level don't buy."

STMicroelectronics: "It's one of those stocks that a lot of people feel is going to get a takeover bid. I don't know. I think the stock has had a nice move. It still remains inexpensive. I still like the semiconductor space. Watch this NVIDIA coming down, that could be an opportunity."

PBF Energy: "Refining, I am not there. I prefer to have let's just say, I like the yield from the master limited partnerships. Maybe buy a basket of master limited partnerships. It might be a good idea."

Cerner Corporation: "I'm glad you used the term 'long term' ... because short term I think that Cerner is a little shaky here. But longer term I really like any company that gives you a healthcare solution that brings down the cost of healthcare. That is a secular-positive story."

Trade Desk: "We all think that one is way too dangerous."

Advanced Micro Devices: "They report next week. They did a big refinancing, which I was in favor. That caused a lot of people to think it was not going to be taken over. I don't recommend stocks on a takeover basis, but I think AMD is coming back though. But don't be surprised, maybe buy some before [earnings] and some after. There could be a little sell-off."

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram - Vine

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com